InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2023-12-04 00:00:00 ET · period of report 2023-12-01 · accession 0001576280-23-000199 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-12-04 2023-12-01 GH Kalia Kumud CIO M - OptEx $0.00 +710 12.1K +6% $0
D 2023-12-04 2023-12-01 GH Kalia Kumud CIO F - Tax $26.33 -353 11.7K -3% -$9,294
D 2023-12-04 2023-12-01 GH Kalia Kumud CIO S - Sale+OE $26.37 -5,800 5,926 -49% -$152.9K
D 2023-12-04 2023-12-01 GH Kalia Kumud CIO M - OptEx $0.00 -710 4,972 -12% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common COMMON STOCK 2023-12-01 M A 710 $0.00 12,079 D — —
2 Common COMMON STOCK 2023-12-01 F D 353 $26.33 11,726 D — — (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
3 Common COMMON STOCK 2023-12-01 S D 5,800 $26.37 5,926 D — — (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.36 to $26.395 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4 Derivative RESTRICTED STOCK UNITS 2023-12-01 M D 710 $0.00 4,972 D $0.00 · — to — 710 COMMON STOCK (F3) The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. (F4) Not applicable for Restricted Stock Units.